ANALYST RECOMMENDATIONS : Abbott Laboratories, Boston Scientific, Costco, Medtronic, Valero Energy...

Every day, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain stocks or the market sentiment on a company.

 

• A. O. Smith Corp: Longbow Research upgrades to buy from neutral. PT up 24% to $71.
• Abbott Laboratories: Wolfe Research initiated coverage with a recommendation of underperform. PT set to $95.
• Avid Technology: J.P. Morgan reinstated coverage with a recommendation of overweight. PT set to $33.
• Boston Scientific: Wolfe Research initiated coverage  with a recommendation of outperform. PT set to $43.
• Callon Petroleum: RBC Capital Markets upgrades to outperform from sector perform. PT jumps 109% to $75.
• Continental Resources: RBC Capital Markets downgrades to sector perform from outperform. PT up 25% to $80.
• Costco Wholesale: Evercore ISI lowers Price Target to $520 from $535, maintains Outperform rating.
• Earthstone: RBC Capital Markets downgrades to sector perform from outperform. PT rises 69% to $21.
• EOG Resources: RBC Capital Markets downgrades to sector perform from outperform. PT up 43% to $150.
• Intertek: Jefferies downgrades from buy to hold saying GBp 4700.
• Littelfuse: Baird cut the recommendation to neutral from outperform. PT up 7.2% to $269.
• Medtronic: Wolfe Research initiated coverage with a recommendation of underperform. PT set to $85.
• Pioneer Natural: RBC Capital Markets downgrades to sector perform from outperform. PT up 35% to $290.
• Sage: Barclays moves from Underweight to Equal-Weight targeting GBp 720.
• Teleflex: Wolfe Research initiated coverage with a recommendation of outperform. PT up 19% to $300.
• Valero Energy: Barclays raises Price Target to $133 from $120, maintains Overweight rating.